Literature DB >> 1733296

Suppression of blood flow autoregulation plateau during nitric oxide blockade in canine kidney.

D S Majid1, L G Navar.   

Abstract

We examined the autoregulation of renal blood flow (RBF) and renal function in anesthetized dogs during nitro-L-arginine (NLA)-induced blockade of endothelium-derived nitric oxide (EDNO). Intrarenal infusion of NLA (50 micrograms.kg-1.min-1) increased systemic arterial pressure (AP) and renal vascular resistance (RVR). RBF decreased by 27 +/- 3%, but glomerular filtration rate remained unchanged. There were reductions in urine flow (24 +/- 5%), urinary sodium excretion (42 +/- 10%), and fractional excretion of sodium (40 +/- 11%). The vasodilatory responses to intrarenal injections of ATP (1, 5, 10 microM) were reversed, whereas such responses to doses (10, 50, 100 ng) of acetylcholine (ACh) were attenuated during NLA infusion. Indomethacin (5 mg/kg iv) treatment further reduced but did not completely abolish ACh-induced vasodilation, suggesting that factor(s) other than EDNO and prostaglandins may also mediate ACh-induced vasodilation in the kidney. Although there was a suppression of the plateau of the AP-RBF relationship with a rightward shift in the slope of the linear portion of the curve during EDNO blockade, the normal autoregulatory pattern remained intact. Similar responses were seen in dogs treated with the angiotensin-converting enzyme inhibitor, MK-422. These data indicate that EDNO contributes to the normally low renal vascular tone by influencing an autoregulation-independent component of RVR. However, the basic capability to adjust RVR (autoregulation-responsive component) in response to changes in AP is essentially autonomous from EDNO activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733296     DOI: 10.1152/ajprenal.1992.262.1.F40

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

1.  Endothelin mediates renal vascular memory of a transient rise in perfusion pressure due to NOS inhibition.

Authors:  X Z Zhang; C Baylis
Journal:  Am J Physiol       Date:  1999-04

2.  Nitric oxide synthase in macula densa regulates glomerular capillary pressure.

Authors:  C S Wilcox; W J Welch; F Murad; S S Gross; G Taylor; R Levi; H H Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

Review 3.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

4.  ATP, P2 receptors and the renal microcirculation.

Authors:  Edward W Inscho
Journal:  Purinergic Signal       Date:  2009-03-18       Impact factor: 3.765

5.  Involvement of endothelium-derived relaxing factor in the pressure control of renin secretion from isolated perfused kidney.

Authors:  H Scholz; A Kurtz
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

Review 6.  Paracrine interactions regulating renal microcirculatory function.

Authors:  L G Navar; E W Inscho; L M Harrison-Bernard; T Takenaka
Journal:  Clin Investig       Date:  1994-09

7.  Intrarenal haemodynamic and glomerular responses to inhibition of nitric oxide formation in rabbits.

Authors:  K M Denton; W P Anderson
Journal:  J Physiol       Date:  1994-02-15       Impact factor: 5.182

8.  Eicosanoid-dependence of responses of pre- but not postglomerular vessels to noradrenaline in rat isolated kidneys.

Authors:  B L Zhang; J Sassard
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

9.  Reduced renal responses to nitric oxide synthase inhibition in mice lacking the gene for gp91phox subunit of NAD(P)H oxidase.

Authors:  Mohammed Z Haque; Dewan S A Majid
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-02

10.  Flow modulates myogenic responses in isolated microperfused rabbit afferent arterioles via endothelium-derived nitric oxide.

Authors:  L A Juncos; J Garvin; O A Carretero; S Ito
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.